CRD-1968099
Oncology/Immunology
PreclinicalActive
Key Facts
About Chordia Therapeutics
Japanese biotech developing novel small molecule kinase inhibitors for oncology and immunology, with multiple clinical-stage assets.
View full company profileTherapeutic Areas
Other Oncology/Immunology Drugs
| Drug | Company | Phase |
|---|---|---|
| BTK | Recludix Pharma | Pre-clinical |